# Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients

> **NCT01261832** · PHASE4 · UNKNOWN · sponsor: **Korea University Guro Hospital** · enrollment: 951 (estimated)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** antiplatelet therapy

## Key facts

- **NCT ID:** NCT01261832
- **Lead sponsor:** Korea University Guro Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2020-02
- **Final completion:** 2022-03
- **Target enrollment:** 951 (ESTIMATED)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01261832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01261832, "Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01261832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*